John Meady

NASDAQ losers: Chelsea Therapeutics International (NASDAQ:CHTP), Pharmacyclics (NASDAQ:PCYC), ZIOPHARM Oncology (NASDAQ:ZIOP), Array Biopharma (NASDAQ:ARRY)

Some drugs that have gained approval this year so far include AstraZeneca’s Myalept (complications of leptin deficiency) and Farxiga (type II diabetes), Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) (to treat neurogenic orthostatic hypotension), BioMarin’s Vimizim (Morquio A syndrome) and Vanda Pharma’s Hetlioz. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) stock performance was -5.75% in last session and finished…

Read More

Services sector bearish Stocks: VisionChina Media (NASDAQ:VISN), 500.com (NYSE:WBAI), China Distance Education Hldgs (NYSE:DL), Shutterstock Inc (NYSE:SSTK)

VisionChina Media Inc. (ADR) (NASDAQ:VISN), one of China’s largest out-of-home digital television advertising networks on mass transportation systems, today announced it has entered into a strategic partnership with China United Network Communications Group Co., Ltd. (“China Unicom”), China’s second largest mobile communications operator. VisionChina Media Inc (ADR) (NASDAQ:VISN) stock performance was -13.14% in last session…

Read More